| Virus‐like particles: Next‐generation nanoparticles for targeted therapeutic delivery MJ Rohovie, M Nagasawa, JR Swartz Bioengineering & translational medicine 2 (1), 43-57, 2017 | 343 | 2017 |
| Characterization of [FeFe] hydrogenase O2 sensitivity using a new, physiological approach J Koo, S Shiigi, M Rohovie, K Mehta, JR Swartz Journal of Biological Chemistry 291 (41), 21563-21570, 2016 | 24 | 2016 |
| Virus-like particles: next-generation nanoparticles for targeted therapeutic delivery. Bioeng. Transl. Med. 2, 43–57 MJ Rohovie, M Nagasawa, JR Swartz Wiley Online Library, 2017 | 5 | 2017 |
| Influence of chain length on the diffusion and electrophoresis of dna adsorbed on heterogeneous supported lipid bilayers K Athmakuri, M Rohovie, C Padala, R Cole, RS Kane Langmuir 26 (16), 13393-13398, 2010 | 3 | 2010 |
| Development of high temperature, flexible polyimide aerogels BN Nguyen, MAB Meador, S Ercegorvic, M Rohovie, L McCorkle, J Guo, ... Polym. Prepr 52, 256, 2011 | 2 | 2011 |
| Metal oxide nanowire growth for nanotechnology-enhanced device applications MM Oye, J Gacusan, O Lenz, T Ngo-Duc, JM Velazquez, E Arreola, ... Nanoepitaxy: Materials and Devices III 8106, 36-43, 2011 | 1 | 2011 |
| Recombinant factor viii variants JD Heredia, ND Kruse, AL Petkova, M Rohovie, AP Silverman US Patent App. 18/150,761, 2023 | | 2023 |
| Engineered enone reductase and ketoreductase variant enzymes C Ching, D Elgart, S Jenne, LL Matzdorff, J Nazor, M Rohovie, ZM Seibel US Patent App. 18/163,132, 2023 | | 2023 |
| Engineered hepatitis b core polypeptide JR Swartz, R Mathew, MJ Rohovie, M Nagasawa US Patent App. 17/581,655, 2022 | | 2022 |
| Improving the Treatment of Hemophilia A with Directed Evolution of the Factor VIII Transgene M Rohovie, J Heredia, N Kruse, R Thibodeau, A Petkova, S Desautel, ... MOLECULAR THERAPY 30 (4), 174-174, 2022 | | 2022 |
| Engineered hepatitis B core polypeptide JR Swartz, R Mathew, MJ Rohovie, M Nagasawa US Patent 11,261,216, 2022 | | 2022 |
| Mucin-binding fusion proteins M Rohovie, N Dellas, MHA Ismaili US Patent App. 17/155,720, 2021 | | 2021 |
| Evolution of a modular, multi-functional targeted delivery nanoparticle J Swartz, M Rohovie, R Mathew, M Nagasawa | | 2019 |
| Engineering Virus-Like Particles for Targeted Delivery of Macromolecular Therapeutics MJ Rohovie Stanford University, 2018 | | 2018 |
Maya NagasawaStanford University在 stanford.edu 的电子邮件经过验证
Maya NagasawaStanford University在 stanford.edu 的电子邮件经过验证